ATS View
한국어

Pharmaceuticals Korean listed companies

Grouped by the industry code each company registered with DART. Sorted by latest quarterly operating profit.

한국어
Companies19
Operating profit₩1.47tnlatest quarter, combined
Operating losses3
Average dividend yield1.3%13 payers

There are 19 KOSPI and KOSDAQ companies classified under pharmaceuticals. Combined operating profit for the latest reported quarter across 19 of them was ₩1.47tn; 3 posted an operating loss. The largest by quarterly operating profit were Samsung Biologics, Celltrion and Hanmi Pharm. 13 paid a cash dividend, with an average reported yield of 1.3%.

Pharmaceuticals companies

CompanyLatest quarter op. profitDividend yieldArticles 30dSignals
Samsung Biologics KOSPI₩586bn
+23% YoY		–78Op. margin 20%+ Supply contract
Celltrion KOSPI₩452bn
+86% YoY		–16Profit +50% Revenue +30% Revenue & profit growth Op. margin 20%+
Hanmi Pharm KOSPI₩131bn
+117% YoY		0.8%49Profit +50% Revenue & profit growth Op. margin 20%+ Share pledge Dividend grower
Daewoong Pharma KOSPI₩68.1bn
+18% YoY		0.3%31News surge Revenue & profit growth
Yuhan KOSPI₩66.9bn
+34% YoY		0.5%92Revenue & profit growth Insider buying Supply contract Dividend grower
PharmaResearch KOSDAQ₩66.5bn
+19% YoY		0.9%13Revenue & profit growth Op. margin 20%+ Dividend grower
DongKookPharmaceutical KOSDAQ₩26.1bn
+18% YoY		1.1%42Revenue & profit growth
Boryung KOSPI₩23.8bn
-6% YoY		1.7%83M&A / stake deal
Chong Kun Dang Pharmaceutical KOSPI₩18.6bn
-21% YoY		0.6%74Dividend cut
ST Pharm KOSDAQ₩18.3bn
+42% YoY		0.3%32Revenue +30% Revenue & profit growth
Medy-Tox KOSDAQ₩4.8bn
-25% YoY		1.0%19–
Yuyu Pharma KOSPI₩4.0bn
+78% YoY		2.5%21Profit +50%
Huons KOSDAQ₩2.9bn
-78% YoY		3.3%20–
Kwangdong Pharmaceutical KOSPI₩2.8bn
-38% YoY		1.1%23–
GC Biopharma KOSPI₩1.7bn
-94% YoY		–54–
Bukwang Pharmaceutical IND KOSPI₩1.4bn
-30% YoY		3.3%18Revenue +30%
Daewon Pharmaceutical KOSPI−₩9m–29–
Vivozon Pharmaceutical KOSDAQ−₩1.9bn–104 quarters of losses
DongKoo Bio & Pharma KOSDAQ−₩6.5bn
-434% YoY		–11Swung to loss

Industry codes are the primary business each company registered with DART and may not reflect its full business mix. Figures come from DART filings; prices are not included. Not investment advice.